Table 8.
Characteristics of the malarial VL co-infected patients versus the non-malarial VL patients enrolled in the MSF’s clinical trial at Um-el-Kher and Kassab Hospitals, Sudan (1998)
| Variable | Cases n (%) | Controls n (%) | Crude Odds Ratio | 95% Confidence Interval |
|---|---|---|---|---|
|
Age |
89 |
427 |
|
|
| Median (years), (interquartile range) |
7 (4-14) |
10 (6-17) |
|
|
|
Treatment center |
89 |
427 |
|
|
| Kassab Hospital |
17 (19.1) |
134 (31.4) |
1 |
|
| Um-el-Kher Hospital |
72 (80.9) |
293 (68.6) |
1.94 |
1.10-3.41* |
|
Fatal outcome |
89 |
427 |
|
|
| No |
79 (88.8) |
415 (97.2) |
1 |
|
| Yes |
10 (11.2) |
12 (2.8) |
4.38 |
1.83-10.48* |
|
Hb level |
89 |
427 |
|
|
| Median (g/dl), (interquartile range) |
7.5 (6.0-9.0) |
8.2 (7.0-9.4) |
|
|
| ≥5.3 g/dl |
75 (84.3) |
405 (94.8) |
1 |
|
| <5.3 g/dl |
14 (15.7) |
22 (5.2) |
3.44 |
1.68-7.02* |
|
Nutritional status |
68 |
299 |
|
|
| Mean Weigh for Height (%) |
78.8 |
80.4 |
|
|
| Weight for Height Percent ≥70% |
60 (88.2) |
279 (93.3) |
1 |
|
| Weight for Height Percent <70% |
8 (11.8) |
20 (6.7) |
1.86 |
0.78-4.42 |
|
Spleen size below the costal margin |
80 |
389 |
|
|
| Median (cm), (interquartile range) |
6 (3-8) |
7 (4-10) |
|
|
| <6 cm |
33 (41.2) |
144 (37.0) |
1 |
|
| ≥6 cm |
47 (58.8) |
245 (63.0) |
0.84 |
0.51-1.37 |
|
Duration on-going sickness |
86 |
422 |
|
|
| Median (days), (interquartile range) |
30 (15-60) |
30 (20-60) |
|
|
| <60 days |
62 (72.1) |
286 (67.8) |
1 |
|
| ≥60 days | 24 (27.9) | 136 (32.2) | 0.81 | 0.49-1.36 |
*P-value <0.05 based on Person Chi-square test.